Does 6% hydroxyethyl starch 130/0.4 impact differently on blood glucose than 4% gelatin in patients receiving open heart surgery?

Perfusion. 2012 Mar;27(2):113-8. doi: 10.1177/0267659111426920. Epub 2011 Oct 14.

Abstract

Objectives: To investigate whether starch-based colloid may impact differently on blood glucose than a gelatin-based colloid in adult patients receiving open heart surgery.

Methods: 70 adult patients scheduled for elective first-time cardiac surgery were enrolled and randomized into two groups. The circuits were primed with either 6% HES 130/0.4 or 4% gelatin. The peak glucose level, incidence of hyperglycemia, glucose variation and glucose level at different time points during operation were compared between the two groups. A p-value ≤ 0.05 was accepted as significant.

Results: The peak glucose (150±30mg/dl vs 142±27, p=0.236) and glucose variation demonstrated by standard deviation (26±12mg/dl vs 23±11mg/dl, p=0.202) were comparable between the two groups. Repeated measurement ANOVA revealed that the main effect for artificial colloid was not significant (p=0.349).

Conclusions: With the data available, we could not prove that starch-based colloid (HES130) had a different impact on intra-operative blood glucose than a gelatin-based colloid in adult patients receiving open heart surgery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Analysis of Variance
  • Blood Glucose / metabolism*
  • Cardiopulmonary Bypass
  • Female
  • Gelatin / therapeutic use*
  • Humans
  • Hydroxyethyl Starch Derivatives / therapeutic use*
  • Male
  • Middle Aged
  • Plasma Substitutes / therapeutic use*
  • Thoracic Surgery*

Substances

  • Blood Glucose
  • HES 130-0.4
  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Gelatin